Translating today's discoveries in childhood cancer research into tomorrow's treatments.

Greehey Children’s Cancer Research Institute is only one of two institutes in the United States dedicated solely to pediatric cancer research. Its 20 laboratories focus their strengths in cancer genomics, DNA repair, RNA biology, and drug development on finding new and less toxic treatments for childhood cancers.

Our research strengths include cancer genomics, DNA damage, RNA biology, and drug development. We are developing expertise in drug delivery, with a focus on the nanotechnology-driven delivery of small RNA mimics and inhibitors.

Learn More


Help Make a Difference

Top stories

panneerdoss-photograph-csa-department

Panneerdoss Subbarayalu, PhD, to receive NIH, NCI R21 Grant, “Targeting the RNA Modifying Enzyme ALKBH5 in Medulloblastoma

Allison Grimes MD

Allison Grimes, M.D., MSCI, Awarded $999K CPRIT Grant to Study “Expansion of HPV Vaccination Among Survivors of Childhood Cancer”

Kitagawa 200x225

Katsumi Kitagawa, Pharm.D., PhD, to Receive NIH Grant to study “The Role of EWSR1 at the Centromere.”

Nature Mag Cover

Nature: Structural Insights into BCDX2 Complex Function in Homologous Recombination (Sung Lab)